BACKGROUND Controversy over blood pressure (BP) treatment targets for individuals with diabetes is in part due to
0.7 to 1.06) (6) . Further, participants in the intensive BP treatment arm of the ACCORD BP trial experienced more serious adverse events related to BP medications than participants in the standard arm (serious adverse event rate 3.3% vs. 1.3%; p < 0.0001) (6) . PARTICIPANTS. A C C O R D B P t r i a l . Detailed information on the study design and main outcomes of the ACCORD BP trial were previously published (6) . In brief, the ACCORD trial enrolled 10,251 type 2 diabetes patients with a history of a hemoglobin A 1c (HbA 1c ) >7.5%, and cardiovascular disease (if age >40 years) or high cardiovascular risk (if age >55 years) to an intensive versus standard glycemic control strategy. Berkowitz et al. Berkowitz et al.
S E P T E M B
from those without hypertension, we did not have explicit hypertension-related inclusion criteria in our main analyses. However, to investigate whether this decision could affect the results, we performed 2 sensitivity analyses. In the first, in addition to the aforementioned criteria, we also required a selfreport of hypertension diagnosis, a self-report of The Kaplan-Meier estimates of experiencing the ACCORD BP primary outcome (a composite of first occurrence of nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death), in the unweighted (left) and weighted (right) analyses. ACCORD ¼ Action to Control Cardiovascular Risk in Diabetes trial; BP ¼ blood pressure.
Berkowitz et al.
Intensive Blood Pressure Control in Diabetes 180 mm Hg, which closely matches an ACCORD BP eligibility criterion (6). riates, divided by their individual probability of being in the ACCORD trial, conditional on the aforementioned covariates. The odds were then multiplied by a stabilization factor, which was the unconditional probability of being included in the ACCORD trial divided by the unconditional probability of not being included. In mathematical terms, the stabilized inverse odds of selection were:
ð1 À pjZÞ=ðpjZÞ$ðp=1 À pÞ where p is the probability of selection and Z is the vector of individual covariates. To estimate the conditional probability of selection, we fit a logistic regression model (Online Table 1 ) with the outcome of being in the ACCORD trial and the above covariates;
NHANES sampling weights were then multiplied by the calculated selection weights to generate a nationally-representative population. The unconditional probability of selection was based on a null (intercept-only) logistic regression model, again incorporating NHANES weights. As a robustness check, we re-estimated the probabilities using a machine learning approach that can capture nonlinearity between covariates and the outcome and complex interactions among covariates in a more sophisticated manner than standard logistic regression (Online All estimates represent hazard ratios (HRs) and 95% confidence intervals (CIs) from proportional hazards regression models except for serious adverse events which represents incidence rate ratios from negative binomial models. Models are adjusted for intensive versus standard glycemic therapy, clinical network, and history of cardiovascular disease at baseline.
BP ¼ blood pressure; IRR ¼ incidence rate ratio.
Berkowitz et al. For results on the absolute scale, we calculated number of events per 1,000 person-years of followup, and plotted the survival function for time-toevent outcomes using Kaplan-Meier methods. We applied log-rank tests for significance of time-toevent outcomes, and the Wilcoxon 2-sample test (Mann-Whitney U test) for serious adverse events with a design correction factor for weighted analyses.
S e n s i t i v i t y a n d r o b u s t n e s s c h e c k s .
First, we conducted Cox/negative binomial regression analyses adjusting for factors that had an absolute standardized difference >0.2 after weighting, to correct for residual imbalance between the weighted ACCORD BP trial population and the NHANES population.
Second, we repeated analyses using a targeted maximum likelihood estimation approach, which has been shown to be less sensitive to positivity violations (cases where some combinations of important covariates are not observed in both the ACCORD BP and NHANES datasets) (9,10). Next, we fit nested conditional probability models to identify combinations of characteristics that might be responsible for differences in transported and untransported treatment effects. These models sequentially added subsets of the full set of cardiovascular risk factors based on imbalance between the ACCORD BP sample and the overall population. Finally, we fit the same weighted proportional hazards models in samples that additionally required hypertension-related inclusion criteria, as described above, to be met. Table 1) .
TRANSPORTED RESULTS FROM ACCORD BP TO
NHANES. After weighting the ACCORD BP population to NHANES, the weighted ACCORD BP sample was more representative of the overall population, but as would be expected by the study design, some BP ¼ blood pressure.
Berkowitz et al. In sensitivity analyses that adjusted for residually imbalanced factors (race/ethnicity, education, diastolic BP, FPG, HbA 1c , triglycerides, and years with diabetes), point estimates were more strongly in favor of intensive BP therapy than in the weighted but unadjusted analyses (Online Table 3 ), though adjustment did not produce any qualitative changes. In sensitivity analyses additionally requiring hypertension diagnosis or elevated BP as inclusion criteria, estimates were similar to the main analyses (Online Tables 4 and 5 ). In sensitivity analyses using targeted maximum likelihood estimation, estimates
were again more strongly in favor of intensive BP Demographic characteristics weighting includes age, sex, race/ethnicity, education, and health insurance status. Clinical risk factors weighting includes smoking status, history of myocardial infarction, history of congestive heart failure, history of stroke, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, hemoglobin A 1c , fasting plasma glucose, glomerular filtration rate, urinary albumin to creatinine ratio, and body mass index. Two models specifically explore the influence of factors that were particularly unbalanced when weighting for all factors. By weighting only for these subsets of factors, we can achieve better balance on them then when weighting for the totality of the factors. For these analyses, subset 1 includes race/ethnicity, education, systolic blood pressure, triglycerides, high-density lipoprotein cholesterol, and urine albumin to creatinine ratio. Subset 2 adds years of diabetes duration to subset 1. Fully weighted includes all demographic characteristics and clinical risk factors.
therapy (Online Table 6 ). In analyses using nested models, weighting for demographic factors or clinical risk factors only did not fully explain the differences between unweighted and weighted results, but the combination of demographic and clinical factors (particularly race/ethnicity, education, SBP, triglycerides, high-density lipoprotein cholesterol, urine albumin to creatinine ratio, and years of diabetes duration) yielded results most similar to the "fully"
weighted results (Figure 1 , Online Tables 7 and 8 ). 
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